Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against AVITA Medical, Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is AVITA Medical, Inc. (RCEL) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AVITA Medical, Inc. (“AVITA” or “the Company”) (NASDAQ: RCEL). Investors who purchased AVITA securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether AVITA has violated federal securities laws.
What Potential Securities Violations Is BG&G Investigating?
On October 16, 2025, after market close, AVITA issued a press release called “AVITA Medical Announces CEO Transition.” It stated that the Company had “effective immediately,” named an Interim Chief Executive Officer, and that in “conjunction with this appointment, Jim Corbett is leaving his positions as CEO and member of the Board.” Following this news, AVITA stock fell 25.8% on October 17, 2025.
What’s Next?
If you are aware of any facts relating to this investigation or purchased AVITA securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
How Is AVITA Medical, Inc. (NASDAQ: RCEL) Stock Trading Today?
Interactive chart showing the weekly share price history of RCEL (RCEL).
How Does BG&G Help Investors in Securities Fraud Investigations?
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”